Abstract
Antibody phage display is the most used in vitro technology to generate recombinant, mainly human, antibodies as tools for research, for diagnostic assays, and for therapeutics. Up to now (autumn 2018), eleven FDA/EMA-approved therapeutic antibodies were developed using phage display, including the world best-selling antibody adalimumab.
A key to generate successfully human antibodies in vitro is the choice of the most appropriate antibody selection method, for our goal. In this book chapter, we describe the antibody selection process (panning) in solution and its advantages over panning on immobilized antigens. Detailed protocols on the panning procedure and the screening of monoclonal binders are given.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Winter G, Milstein C (1991) Man-made antibodies. Nature 349:293–299. https://doi.org/10.1038/349293a0
Parmley SF, Smith GP (1988) Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 73:305–318
McCafferty J, Griffiths AD, Winter G, Chiswell DJ (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552–554. https://doi.org/10.1038/348552a0
Barbas CF, Kang AS, Lerner RA, Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A 88:7978–7982
Breitling F, Dübel S, Seehaus T, Klewinghaus I, Little M (1991) A surface expression vector for antibody screening. Gene 104:147–153. https://doi.org/10.1016/0378-1119(91)90244-6
Hust M, Meyer T, Voedisch B, Rülker T, Thie H, El-Ghezal A, Kirsch MI, Schütte M, Helmsing S, Meier D, Schirrmann T, Dübel S (2011) A human scFv antibody generation pipeline for proteome research. J Biotechnol 152:159–170. https://doi.org/10.1016/j.jbiotec.2010.09.945
Schofield DJ, Pope AR, Clementel V, Buckell J, Chapple SD, Clarke KF, Conquer JS, Crofts AM, Crowther SR, Dyson MR, Flack G, Griffin GJ, Hooks Y, Howat WJ, Kolb-Kokocinski A, Kunze S, Martin CD, Maslen GL, Mitchell JN, O’Sullivan M, Perera RL, Roake W, Shadbolt SP, Vincent KJ, Warford A, Wilson WE, Xie J, Young JL, McCafferty J (2007) Application of phage display to high throughput antibody generation and characterization. Genome Biol 8:R254. https://doi.org/10.1186/gb-2007-8-11-r254
Hoet RM, Cohen EH, Kent RB, Rookey K, Schoonbroodt S, Hogan S, Rem L, Frans N, Daukandt M, Pieters H, van Hegelsom R, Neer NC, Nastri HG, Rondon IJ, Leeds JA, Hufton SE, Huang L, Kashin I, Devlin M, Kuang G, Steukers M, Viswanathan M, Nixon AE, Sexton DJ, Hoogenboom HR, Ladner RC (2005) Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nat Biotechnol 23:344–348. https://doi.org/10.1038/nbt1067
Omar N, Lim TS (2018) Construction of Naive and Immune Human Fab Phage-Display Library. Methods Mol Biol 1701:25–44. https://doi.org/10.1007/978-1-4939-7447-4_2
Holt LJ, Herring C, Jespers LS, Woolven BP, Tomlinson IM (2003) Domain antibodies: proteins for therapy. Trends Biotechnol 21:484–490. https://doi.org/10.1016/j.tibtech.2003.08.007
Romão E, Poignavent V, Vincke C, Ritzenthaler C, Muyldermans S, Monsion B (2018) Construction of high-quality camel immune antibody libraries. Methods Mol Biol 1701:169–187. https://doi.org/10.1007/978-1-4939-7447-4_9
Hawlisch H, Müller M, Frank R, Bautsch W, Klos A, Köhl J (2001) Site-specific anti-C3a receptor single-chain antibodies selected by differential panning on cellulose sheets. Anal Biochem 293:142–145
Moghaddam A, Borgen T, Stacy J, Kausmally L, Simonsen B, Marvik OJ, Brekke OH, Braunagel M (2003) Identification of scFv antibody fragments that specifically recognise the heroin metabolite 6-monoacetylmorphine but not morphine. J Immunol Methods 280:139–155
Hust M, Maiss E, Jacobsen H-J, Reinard T (2002) The production of a genus-specific recombinant antibody (scFv) using a recombinant potyvirus protease. J Virol Methods 106:225–233
Schütte M, Thullier P, Pelat T, Wezler X, Rosenstock P, Hinz D, Kirsch MI, Hasenberg M, Frank R, Schirrmann T, Gunzer M, Hust M, Dübel S (2009) Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS One 4:e6625. https://doi.org/10.1371/journal.pone.0006625
Thie H, Toleikis L, Li J, von Wasielewski R, Bastert G, Schirrmann T, Esteves IT, Behrens CK, Fournes B, Fournier N, de Romeuf C, Hust M, Dübel S (2011) Rise and fall of an anti-MUC1 specific antibody. PLoS One 6:e15921. https://doi.org/10.1371/journal.pone.0015921
Keller T, Kalt R, Raab I, Schachner H, Mayrhofer C, Kerjaschki D, Hantusch B (2015) Selection of scFv antibody fragments binding to human blood versus lymphatic endothelial surface antigens by direct cell phage display. PLoS One 10:e0127169. https://doi.org/10.1371/journal.pone.0127169
Rezaei J, RajabiBazl M, Ebrahimizadeh W, Dehbidi GR, Hosseini H (2016) Selection of single chain antibody fragments for targeting prostate specific membrane antigen: a comparison between cell-based and antigen-based approach. Protein Pept Lett 23:336–342
Frenzel A, Kügler J, Wilke S, Schirrmann T, Hust M (2014) Construction of human antibody gene libraries and selection of antibodies by phage display. Methods Mol Biol 1060:215–243. https://doi.org/10.1007/978-1-62703-586-6_12
Ayriss J, Woods T, Bradbury A, Pavlik P (2007) High-throughput screening of single-chain antibodies using multiplexed flow cytometry. J Proteome Res 6:1072–1082. https://doi.org/10.1021/pr0604108
Jäger V, Büssow K, Wagner A, Weber S, Hust M, Frenzel A, Schirrmann T (2013) High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells. BMC Biotechnol 13:52. https://doi.org/10.1186/1472-6750-13-52
Trott M, Weiβ S, Antoni S, Koch J, von Briesen H, Hust M, Dietrich U (2014) Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody. PLoS One 9:e97478. https://doi.org/10.1371/journal.pone.0097478
Chan SW, Bye JM, Jackson P, Allain JP (1996) Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library. J Gen Virol 77(10):2531–2539
Glanville J, Zhai W, Berka J, Telman D, Huerta G, Mehta GR, Ni I, Mei L, Sundar PD, Day GMR, Cox D, Rajpal A, Pons J (2009) Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc Natl Acad Sci U S A 106:20216–20221. https://doi.org/10.1073/pnas.0909775106
de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM (2000) Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol 18:989–994. https://doi.org/10.1038/79494
Kügler J, Wilke S, Meier D, Tomszak F, Frenzel A, Schirrmann T, Dübel S, Garritsen H, Hock B, Toleikis L, Schütte M, Hust M (2015) Generation and analysis of the improved human HAL9/10 antibody phage display libraries. BMC Biotechnol 15:10. https://doi.org/10.1186/s12896-015-0125-0
Osbourn J, Groves M, Vaughan T (2005) From rodent reagents to human therapeutics using antibody guided selection. Methods 36:61–68. https://doi.org/10.1016/j.ymeth.2005.01.006
Frenzel A, Schirrmann T, Hust M (2016) Phage display-derived human antibodies in clinical development and therapy. MAbs 8:1177–1194. https://doi.org/10.1080/19420862.2016.1212149
Kirsch M, Hülseweh B, Nacke C, Rülker T, Schirrmann T, Marschall H-J, Hust M, Dübel S (2008) Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol 8:66. https://doi.org/10.1186/1472-6750-8-66
Goletz S, Christensen PA, Kristensen P, Blohm D, Tomlinson I, Winter G, Karsten U (2002) Selection of large diversities of anti-idiotypic antibody fragments by phage display. J Mol Biol 315:1087–1097
Finnern R, Pedrollo E, Fisch I, Wieslander J, Marks JD, Lockwood CM, Ouwehand WH (1997) Human autoimmune anti-proteinase 3 scFv from a phage display library. Clin Exp Immunol 107:269–281
Hust M, Steinwand M, Al-Halabi L, Helmsing S, Schirrmann T, Dübel S (2009) Improved microtitre plate production of single chain Fv fragments in Escherichia coli. New Biotechnol 25:424–428. https://doi.org/10.1016/j.nbt.2009.03.004
Goffinet M, Chinestra P, Lajoie-Mazenc I, Medale-Giamarchi C, Favre G, Faye J-C (2008) Identification of a GTP-bound Rho specific scFv molecular sensor by phage display selection. BMC Biotechnol 8:34
Lillo AM, Ayriss JE, Shou Y, Graves SW, Bradbury ARM (2011) Development of phage-based single chain Fv antibody reagents for detection of Yersinia pestis. PLoS One 6:e27756. https://doi.org/10.1371/journal.pone.0027756
Russo G, Meier D, Helmsing S, Wenzel E, Oberle F, Frenzel A, Hust M (2018) Parallelized antibody selection in microtiter plates. In: Hust M, Lim TS (eds) Phage display: methods and protocols. Springer, New York, NY, pp 273–284
Kuhn P, Fühner V, Unkauf T, Moreira GMSG, Frenzel A, Miethe S, Hust M (2016) Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display. Proteomics Clin Appl 10:922–948. https://doi.org/10.1002/prca.201600002
Acknowledgments
This review contains updated and revised parts of former protocols [35].
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Wenzel, E.V. et al. (2020). Antibody Phage Display: Antibody Selection in Solution Using Biotinylated Antigens. In: Zielonka, S., Krah, S. (eds) Genotype Phenotype Coupling. Methods in Molecular Biology, vol 2070. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9853-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9853-1_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9852-4
Online ISBN: 978-1-4939-9853-1
eBook Packages: Springer Protocols